(ELGX) |
| 0 (0%) 10-10 11:48 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.08 |
| Resistance 1: | 0.05 |
| Pivot price: | 0.04 |
| Support 1: | 0.01 |
| Support 2: | 0.01 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 26 Jun 2024
Lacrimal gland removal impairs sexual behavior in mice - Frontiers
Tue, 11 May 2021
Endologix launches Alto abdominal stent graft in Canada - MassDevice
Mon, 06 Jul 2020
Endologix Initiates Bankruptcy Process, In Deal With Deerfield Partners To Be Taken Private - Nasdaq
Mon, 06 Jul 2020
Endologix files for bankruptcy, will go private - MassDevice
Fri, 18 Aug 2017
FDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal - RTTNews
Tue, 07 Feb 2017
Why Endologix, Inc. Stock Gained 20% in January - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
